Predictors of Patients' Choices for Breast-conserving Therapy or Mastectomy: a Prospective Study

Overview

Journal Br J Cancer

Specialty Oncology

Date 2004 May 20

PMID 15150557

Citations 49

Authors

S Molenaar

F Oort

M Sprangers

E Rutgers

E Luiten

J Mulder

H de Haes

Affiliations

Soon will be listed here.

Abstract

A study was undertaken to describe the treatment preferences and choices of patients with breast cancer, and to identify predictors of undergoing breast-conserving therapy (BCT) or mastectomy (MT). Consecutive patients with stage I/II breast cancer were eligible. Information about predictor variables, including socio-demographics, quality of life, patients' concerns, decision style, decisional conflict and perceived preference of the surgeon was collected at baseline, before decision making and surgery. Patients received standard information (n=88) or a decision aid (n=92) as a supplement to support decision making. A total of 180 patients participated in the study. In all, 72% decided to have BCT (n=123); 28% chose MT (n=49). Multivariate analysis showed that what patients perceived to be their surgeons' preference and the patients' concerns regarding breast loss and local tumour recurrence were the strongest predictors of treatment preference. Treatment preferences in itself were highly predictive of the treatment decision. The decision aid did not influence treatment choice. The results of this study demonstrate that patients' concerns and their perceptions of the treatment preferences of the physicians are important factors in patients' decision making. Adequate information and communication are essential to base treatment decisions on realistic concerns, and the treatment preferences of patients.

Citing Articles

Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence.

Seto Y, Ishitobi M, Shien T, Oshiro C, Inoue H, Shima H Ann Surg Oncol. 2024; 31(7):4512-4517.

PMID: 38594578 DOI: 10.1245/s10434-024-15282-0.

What affects women's decision-making on breast reconstruction after mastectomy for breast cancer?.

van Bekkum S, Clarijs M, van der Veen F, van Rosmalen J, Koppert L, Menke-Pluijmers M Breast Cancer. 2023; 30(5):772-784.

PMID: 37303033 DOI: 10.1007/s12282-023-01471-4.

A large single-center prospective study to investigate the factors influencing the choice of breast-conserving surgery versus mastectomy in Chinese women with early breast cancer.

Li Z, Liu Y, Zhang J, Li Y, Du K, Zhang S World J Surg Oncol. 2023; 21(1):43.

PMID: 36765355 PMC: 9921411. DOI: 10.1186/s12957-023-02924-y.

"" in Breast-Conserving Surgery after Neoadjuvant Chemotherapy.

Atzori G, Gipponi M, Cornacchia C, Diaz R, Sparavigna M, Gallo M J Pers Med. 2022; 12(7).

PMID: 35887526 PMC: 9320436. DOI: 10.3390/jpm12071031.

Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112).

Fazeli S, Snyder B, Gareen I, Lehman C, Khan S, Romanoff J JAMA Netw Open. 2022; 5(5):e2210331.

PMID: 35536580 PMC: 9092204. DOI: 10.1001/jamanetworkopen.2022.10331.

References

Nold R, BEAMER R, Helmer S, McBoyle M . Factors influencing a woman's choice to undergo breast-conserving surgery versus modified radical mastectomy. Am J Surg. 2001; 180(6):413-8. DOI: 10.1016/s0002-9610(00)00501-8. View

Charavel M, Bremond A, Moumjid-Ferdjaoui N, Mignotte H, Carrere M . Shared decision-making in question. Psychooncology. 2001; 10(2):93-102. DOI: 10.1002/pon.502. View

Molenaar S, Sprangers M, Rutgers E, Noorlander J, Hendriks J, de Haes H . Feasibility and effects of decision aids. Med Decis Making. 2000; 20(1):112-27. DOI: 10.1177/0272989X0002000114. View

OConnor A . Validation of a decisional conflict scale. Med Decis Making. 1995; 15(1):25-30. DOI: 10.1177/0272989X9501500105. View

OConnor A, Stacey D, Entwistle V, Llewellyn-Thomas H, ROVNER D, Holmes-Rovner M . Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003; (2):CD001431. DOI: 10.1002/14651858.CD001431. View

Cyran E, Crane L, Palmer L . Physician sex and other factors associated with type of breast cancer surgery in older women. Arch Surg. 2001; 136(2):185-91. DOI: 10.1001/archsurg.136.2.185. View

Charles C, Whelan T, Gafni A, Willan A, Farrell S . Shared treatment decision making: what does it mean to physicians?. J Clin Oncol. 2003; 21(5):932-6. DOI: 10.1200/JCO.2003.05.057. View

Kotwall C, Maxwell J, Covington D, Churchill P, Smith S, Covan E . Clinicopathologic factors and patient perceptions associated with surgical breast-conserving treatment. Ann Surg Oncol. 1996; 3(2):169-75. DOI: 10.1007/BF02305797. View

Mastaglia B, Kristjanson L . Factors influencing women's decisions for choice of surgery for Stage I and Stage II breast cancer in Western Australia. J Adv Nurs. 2001; 35(6):836-47. DOI: 10.1046/j.1365-2648.2001.01921.x. View

10.

Sprangers M, Groenvold M, Arraras J, Franklin J, Te Velde A, Muller M . The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996; 14(10):2756-68. DOI: 10.1200/JCO.1996.14.10.2756. View

11.

Sakorafas G, Tsiotou A . Selection criteria for breast conservation in breast cancer. Eur J Surg. 2000; 166(11):835-46. DOI: 10.1080/110241500447209. View

12.

Ward S, Heidrich S, Wolberg W . Factors women take into account when deciding upon type of surgery for breast cancer. Cancer Nurs. 1989; 12(6):344-51. View

13.

Morrow M, White J, Moughan J, Owen J, Pajack T, Sylvester J . Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001; 19(8):2254-62. DOI: 10.1200/JCO.2001.19.8.2254. View

14.

Kiebert G, de Haes J, van de Velde C . The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol. 1991; 9(6):1059-70. DOI: 10.1200/JCO.1991.9.6.1059. View

15.

Whelan T, Levine M, Gafni A, Sanders K, Willan A, Mirsky D . Mastectomy or lumpectomy? Helping women make informed choices. J Clin Oncol. 1999; 17(6):1727-35. DOI: 10.1200/JCO.1999.17.6.1727. View

16.

Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A . Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347(16):1227-32. DOI: 10.1056/NEJMoa020989. View

17.

Gilligan M, Kneusel R, Hoffmann R, Greer A, Nattinger A . Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care. 2002; 40(3):181-9. DOI: 10.1097/00005650-200203000-00002. View

18.

Stafford D, Szczys R, Becker R, Anderson J, Bushfield S . How breast cancer treatment decisions are made by women in North Dakota. Am J Surg. 1999; 176(6):515-9. DOI: 10.1016/s0002-9610(98)00257-8. View

19.

Goldhirsch A, Wood W, Gelber R, Coates A, Thurlimann B, Senn H . Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol. 2003; 21(17):3357-65. DOI: 10.1200/JCO.2003.04.576. View

20.

Fisher B, Anderson S, Bryant J, Margolese R, Deutsch M, Fisher E . Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347(16):1233-41. DOI: 10.1056/NEJMoa022152. View